Baidu
map
J SAUDI CHEM SOC 润色咨询

Journal of Saudi Chemical Society

出版年份：暂无数据 年文章数：910 投稿命中率： 开通期刊会员，数据随心看

出版周期：Bimonthly 自引率：6.5% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1104468, encodeId=3db31104468cb, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104467, encodeId=8fe5110446e4a, content=如何判断两种药物之间是协同作用还是相加作用？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852387, encodeId=f99085238e0f, content=审稿速度:1.0<br>经验分享：很好，支持支持支持支持支持支持 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3de05414115, createdName=ms313574960747337, createdTime=Thu Jul 04 15:19:59 CST 2019, time=2019-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539714, encodeId=e6ce539e14c7, content=一切只能希望明年,毕竟整体在涨就不用担心。哪怕一年只涨一点点，日积月累，也是不错的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=265, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chengqi2017, createdTime=Tue Jul 18 18:31:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=831478, encodeId=e1c38314e84e, content=审稿速度:3.0<br>经验分享：10.12投稿<br> 12.23修改意见 给了3周时间修改<br> 12.31返回修改意见<br> 2016.1.04接收！<br> 感谢沙特阿拉伯众教授！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04b15414042, createdName=ms6291048970344522, createdTime=Mon Jan 04 15:37:26 CST 2016, time=2016-01-04, status=1, ipAttribution=)]
    2021-12-28 MS54455111222

    如果文章发表了未提供ORCIDID如何添加？

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=1104468, encodeId=3db31104468cb, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104467, encodeId=8fe5110446e4a, content=如何判断两种药物之间是协同作用还是相加作用？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852387, encodeId=f99085238e0f, content=审稿速度:1.0<br>经验分享：很好，支持支持支持支持支持支持 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3de05414115, createdName=ms313574960747337, createdTime=Thu Jul 04 15:19:59 CST 2019, time=2019-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539714, encodeId=e6ce539e14c7, content=一切只能希望明年,毕竟整体在涨就不用担心。哪怕一年只涨一点点，日积月累，也是不错的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=265, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chengqi2017, createdTime=Tue Jul 18 18:31:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=831478, encodeId=e1c38314e84e, content=审稿速度:3.0<br>经验分享：10.12投稿<br> 12.23修改意见 给了3周时间修改<br> 12.31返回修改意见<br> 2016.1.04接收！<br> 感谢沙特阿拉伯众教授！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04b15414042, createdName=ms6291048970344522, createdTime=Mon Jan 04 15:37:26 CST 2016, time=2016-01-04, status=1, ipAttribution=)]
    2021-12-27 桑晒麦拉

    如何判断两种药物之间是协同作用还是相加作用？

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=1104468, encodeId=3db31104468cb, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104467, encodeId=8fe5110446e4a, content=如何判断两种药物之间是协同作用还是相加作用？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852387, encodeId=f99085238e0f, content=审稿速度:1.0<br>经验分享：很好，支持支持支持支持支持支持 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3de05414115, createdName=ms313574960747337, createdTime=Thu Jul 04 15:19:59 CST 2019, time=2019-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539714, encodeId=e6ce539e14c7, content=一切只能希望明年,毕竟整体在涨就不用担心。哪怕一年只涨一点点，日积月累，也是不错的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=265, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chengqi2017, createdTime=Tue Jul 18 18:31:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=831478, encodeId=e1c38314e84e, content=审稿速度:3.0<br>经验分享：10.12投稿<br> 12.23修改意见 给了3周时间修改<br> 12.31返回修改意见<br> 2016.1.04接收！<br> 感谢沙特阿拉伯众教授！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04b15414042, createdName=ms6291048970344522, createdTime=Mon Jan 04 15:37:26 CST 2016, time=2016-01-04, status=1, ipAttribution=)]
    2019-07-04 ms313574960747337

    审稿速度:1.0
    经验分享：很好，支持支持支持支持支持支持

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1104468, encodeId=3db31104468cb, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104467, encodeId=8fe5110446e4a, content=如何判断两种药物之间是协同作用还是相加作用？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852387, encodeId=f99085238e0f, content=审稿速度:1.0<br>经验分享：很好，支持支持支持支持支持支持 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3de05414115, createdName=ms313574960747337, createdTime=Thu Jul 04 15:19:59 CST 2019, time=2019-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539714, encodeId=e6ce539e14c7, content=一切只能希望明年,毕竟整体在涨就不用担心。哪怕一年只涨一点点，日积月累，也是不错的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=265, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chengqi2017, createdTime=Tue Jul 18 18:31:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=831478, encodeId=e1c38314e84e, content=审稿速度:3.0<br>经验分享：10.12投稿<br> 12.23修改意见 给了3周时间修改<br> 12.31返回修改意见<br> 2016.1.04接收！<br> 感谢沙特阿拉伯众教授！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04b15414042, createdName=ms6291048970344522, createdTime=Mon Jan 04 15:37:26 CST 2016, time=2016-01-04, status=1, ipAttribution=)]
    2017-07-18 chengqi2017

    一切只能希望明年,毕竟整体在涨就不用担心。哪怕一年只涨一点点，日积月累，也是不错的

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1104468, encodeId=3db31104468cb, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104467, encodeId=8fe5110446e4a, content=如何判断两种药物之间是协同作用还是相加作用？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852387, encodeId=f99085238e0f, content=审稿速度:1.0<br>经验分享：很好，支持支持支持支持支持支持 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3de05414115, createdName=ms313574960747337, createdTime=Thu Jul 04 15:19:59 CST 2019, time=2019-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539714, encodeId=e6ce539e14c7, content=一切只能希望明年,毕竟整体在涨就不用担心。哪怕一年只涨一点点，日积月累，也是不错的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=265, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chengqi2017, createdTime=Tue Jul 18 18:31:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=831478, encodeId=e1c38314e84e, content=审稿速度:3.0<br>经验分享：10.12投稿<br> 12.23修改意见 给了3周时间修改<br> 12.31返回修改意见<br> 2016.1.04接收！<br> 感谢沙特阿拉伯众教授！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04b15414042, createdName=ms6291048970344522, createdTime=Mon Jan 04 15:37:26 CST 2016, time=2016-01-04, status=1, ipAttribution=)]
    2016-01-04 ms6291048970344522

    审稿速度:3.0
    经验分享：10.12投稿
    12.23修改意见 给了3周时间修改
    12.31返回修改意见
    2016.1.04接收！
    感谢沙特阿拉伯众教授！

    0

共7条页码: 1/1页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分

Baidu
Baidu
map
Baidu
map
Baidu
map